Staccato Prochlorperazine in Migraine (Out Patient)
Public ClinicalTrials.gov record NCT00422812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of StaccatoTM Prochlorperazine for Inhalation in Patients With Migraine Headache
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches. In October 2005, we completed a 75 patient, multi-center, double-blind placebo-controlled Phase 2A clinical trial in patients suffering from moderate to severe acute migraine headaches. This Phase 2B clinical trial of Staccato Prochlorperazine has been initiated to assess the efficacy and safety in outpatients with migraine headache with or without aura.
Study identification
- NCT ID
- NCT00422812
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Inhaled Placebo Drug
- Inhaled PCZ 5 mg Drug
- Inhaled PCZ 7.5 mg Drug
- Inhaled PCZ 10 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Actual)
- Primary completion
- Jan 2007 (Actual)
- Completion
- Jan 2007 (Actual)
- Last update posted
- Jan 25, 2018
2006 – 2007
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Department of Neurology, Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| San Francisco Headache Clinic | San Francisco | California | 94109 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Neurological Research Institute of East Bay | Walnut Creek | California | 94596 | — |
| Mile High Research Center | Denver | Colorado | 80218-1110 | — |
| Associated Neurologists of Southern Connecticut PC | Fairfield | Connecticut | 06824 | — |
| Hartford Headache Center | Hartford | Connecticut | 06106 | — |
| The New England Center for Headache | Stamford | Connecticut | 06902 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Palm Beach Neurological Center | West Palm Beach | Florida | 33410 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60614-1726 | — |
| Medvadis | Wellesley Hills | Massachusetts | 02481-2106 | — |
| New England Regional Headache Center | Worcester | Massachusetts | 01605 | — |
| The Michigan Head-Pain and Neurological Institute | Ann Arbor | Michigan | 48104.5199 | — |
| Headache Care Center Primary Care Network, INC | Springfield | Missouri | 65807 | — |
| Regional Clinical Research | Endwell | New York | 13760 | — |
| Elkind Headache Center | Mount Vernon | New York | 10050 | — |
| New York Headache Center | New York | New York | 10021 | — |
| Island Neurological Associates, PC | Plainview | New York | 11803 | — |
| PharmQuest | Greensboro | North Carolina | 27401 | — |
| Health Research Associates | Cleveland | Ohio | 44121 | — |
| ClinExcel Research | West Chester | Ohio | 45069 | — |
| University Neurologists/OUHSC | Oklahoma City | Oklahoma | 73104 | — |
| Houston Headache Clinic | Houston | Texas | 77004 | — |
| Swedish Research Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00422812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2018 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00422812 live on ClinicalTrials.gov.